Jove
Visualize
Contact Us

Related Experiment Videos

Targeting the skin for genetic immunization.

L D Falo1

  • 1Department of Dermatology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, PA 15213, USA.

Proceedings of the Association of American Physicians
|June 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In silico programming of degradable microparticles to hide and then reveal immunogenic payloads in vivo.

Journal of materials chemistry. B·2020
Same author

Electrophilic nitro-fatty acids suppress allergic contact dermatitis in mice.

Allergy·2016
Same author

The immunology of DNA vaccines.

Methods in molecular medicine·2011
Same author

Novel approach to gene expression profiling in Sézary syndrome.

The British journal of dermatology·2010
Same author

Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.

Gene therapy·2009
Same author

'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.

Gene therapy·2005
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

DNA vaccination utilizes antigen-encoding DNA delivered to the skin, leveraging its immune cells for enhanced immunization. This genetic vaccination approach shows promise for overcoming traditional vaccine limitations.

Area of Science:

  • Gene therapy
  • Immunology
  • Dermatology

Background:

  • Recent gene therapy advances enable DNA-based vaccination strategies.
  • The skin presents a unique microenvironment for genetic vaccine delivery.
  • Cutaneous antigen expression can engage antigen-presenting cells and accessory cells.

Purpose of the Study:

  • To explore the potential of DNA-based vaccination targeting the skin.
  • To understand the mechanisms of genetic immunization in a cutaneous context.
  • To investigate the engineering of immune responses via skin delivery.

Main Methods:

  • Delivery of antigen-encoding DNA (plasmids) to the skin.
  • Utilizing the skin's rich population of antigen-presenting cells (e.g., Langerhans cells).

Related Experiment Videos

  • Investigating in vivo transfection and genetic engineering of immune cells.

    • Main Results:

    • Antigen expression in the skin can initiate an immune response.
    • Langerhans cells are susceptible to in vivo transfection.
    • Potential for in vivo genetic engineering of antigen-presenting cells.

    Conclusions:

    • The skin offers unique advantages for DNA vaccination and immune response modulation.
    • Genetic immunization via the skin may overcome historical vaccinology limitations.
    • Co-delivery strategies can potentially induce or suppress antigen-specific immunity.